Emory researchers discover enzyme to combat IgG-mediated disorders

Myasthenia gravis (MG) is a chronic autoimmune disorder in which antibodies block communication between nerves and muscle, resulting in weakness of the skeletal muscles.

AUR-101 by Aurigene Oncology for Ankylosing Spondylitis (Bekhterev’s Disease): Likelihood of Approval

AUR-101 is under clinical development by Aurigene Oncology and currently in Phase II for Ankylosing Spondylitis (Bekhterev’s Disease).

January 9, 2024

CDC’s Tracking a New COVID Variant: BA.2.87.1

The CDC announced last week that it’s tracking a new variant of SARS-CoV-2 — named BA.2.87.1 — given its large number of changes in the

February 16, 2024

ARPA-H finally settles on its headquarters: hubs in Boston, Texas, and D.C.

WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed —

September 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.